Bioavailability & Solubility

WEBINAR - Challenges of Sustained Release Drug Delivery Devices

Sustained release drug delivery is rapidly expanding across respiratory, ophthalmic, transdermal, and implantable applications, but translating products from development to manufacturing remains both complex and costly. Programs can stall due to material–drug compatibility issues, inconsistent release profiles, tooling-related variability, and scale-up challenges between prototyping and GMP-capable small-batch production. Combined with evolving regulatory expectations around extractables and leachables, as well as stringent cleanroom requirements, these obstacles can lead to costly redesigns, delayed timelines, and missed market opportunities.

In this webinar, H&T Presspart and PlasTech Engineering will explore the sustained release device landscape from early feasibility through to small-batch commercialization. We will begin by examining key market drivers and delivery device formats before discussing the development expertise required to de-risk programs. Topics will include defining critical-to-quality attributes, selecting and qualifying materials for performance and stability, and aligning device design with manufacturing requirements.